Misclassification of recovery in dilated cardiomyopathy by echocardiography as compared to cardiac MRI

David Mui1, Yuanwei Xu2, Neal K Pohlman3

  • 1Stanford School of Medicine, Stanford University, Stanford, CA, USA.

Insights

Cardiovascular magnetic resonance (CMR) provides more accurate measurements of cardiac function than 2D transthoracic echocardiography (TTE) in dilated cardiomyopathy (DCM) patients. TTE overestimates ejection fraction, leading to significant misclassification of heart failure status and recovery.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Research

Background:

  • Accurate assessment of cardiac function is crucial for diagnosing and managing dilated cardiomyopathy (DCM).
  • Cardiovascular magnetic resonance (CMR) and 2D transthoracic echocardiography (TTE) are used to assess cardiac function, but their comparative impact on heart failure (HF) classification and ejection fraction (EF) improvement assessment in DCM is not fully understood.

Purpose of the Study:

  • To compare left ventricular (LV) ejection fraction (EF) and volumes measured by CMR and 2D-TTE in DCM patients.
  • To evaluate the impact of these measurement differences on initial HF classification and subsequent assessment of myocardial recovery.

Main Methods:

  • Comparison of LV ejection fraction (LVEF), LV end-diastolic volume (LVEDV), and LV end-systolic volume (LVESV) from 130 DCM patients using CMR and 2D-TTE.
  • Assessment of myocardial recovery in patients with improved EF (HFimpEF) based on both imaging modalities over a 12-48 month follow-up period.

Main Results:

  • 2D-TTE significantly overestimated LVEF (8.3%) and underestimated LVEDV (-69.0 ml) and LVESV (-64.8 ml) compared to CMR.
  • The overestimation of LVEF by TTE was more pronounced at lower EF values.
  • This led to initial misclassification of 60% of heart failure with reduced ejection fraction (HFrEF) patients and misclassification of myocardial recovery in 59% of DCM patients.

Conclusions:

  • 2D-TTE measurements can lead to significant misclassification of heart failure status and myocardial recovery in DCM patients.
  • These discrepancies may impact initial treatment decisions and long-term patient management.
  • CMR offers a more accurate assessment of cardiac function in DCM, crucial for precise HF classification and monitoring treatment efficacy.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
28
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
51
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
137
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
478